You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SYRE Sale Disclosure
Henderson Michael Thomas · SEC Form 4 · Filed Jun 23, 2026
Sale
Calculated transaction value
$2M
Henderson Michael Thomas Director
SYRE
Spyre Therapeutics
SYRE
Transaction date
Jun 22, 2026
Public filing date
Jun 23, 2026
Filing lag
Filed 1 day later
SYRE daily price context
Close on/before transaction
$100.32
Jun 22, 2026
First close after public filing
$86.24
Jun 24, 2026
30-day return after filing
+15.94%
Through Jul 23, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 20,000 shares @ $100
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001636282-26-000084
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$2M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Spyre Therapeutics, Inc. SYRE Current | Sale | Jun 22, 2026 | $2M |